Mobilized bone marrow cells repair the infarcted heart, improving function and survival

Area of Science:

• Regenerative Medicine
• Cardiovascular Biology
• Stem Cell Biology

Background:

• Previous attempts to repair myocardial infarcts using cell transplantation showed limited success in integrating new cells with existing tissue.
• Primitive bone marrow cells (BMC) possess growth and transdifferentiation potential, offering a promising avenue for cardiac repair.
• Tissue damage and a high level of pluripotent cells are critical for BMC transdifferentiation.

Purpose of the Study:

• To investigate if mobilizing BMC with stem cell factor and granulocyte-colony stimulating factor promotes myocardial repair in acute myocardial infarcts.
• To assess the homing, replication, differentiation, and regenerative potential of cytokine-mobilized BMC in infarcted cardiac tissue.

Main Methods:

• BMC were mobilized using stem cell factor and granulocyte-colony stimulating factor in animals with acute myocardial infarcts.
• The study assessed tissue regeneration, mortality, infarct size, cardiac dimensions, and hemodynamic function 27 days post-treatment.
• Histological analysis confirmed the differentiation of BMC into myocytes and vascular structures integrated with the native myocardium.

Main Results:

• Cytokine-mediated BMC translocation led to significant cardiac tissue regeneration.
• Treatment decreased mortality by 68%, infarct size by 40%, and diastolic stress by 70%.
• Formation of new myocytes and integrated vasculature improved ejection fraction and overall cardiac hemodynamics.

Conclusions:

• Mobilization of primitive BMC by cytokines is a viable, noninvasive therapeutic strategy for myocardial regeneration.
• This approach holds potential for treating ischemic heart disease and other cardiac pathologies.
• Cytokine-induced cardiac repair demonstrates significant functional recovery and structural regeneration post-infarction.